@misc{indiciae1d2fbe03fb19,
  title = {Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination With Nivolumab},
  author = {Thudium, K. and Selby, M. and Zorn, J. A. and Rak, G. and Wang, X.-T. and Bunch, R. T. and Hogan, J. M. and Strop, P. and Korman, A. J.},
  year = {2022},
  doi = {10.1101/2022.01.24.477551},
  url = {https://www.biorxiv.org/content/10.1101/2022.01.24.477551v1},
  note = {Source identifier: 10.1101/2022.01.24.477551}
}